Tema Cardiovascular and Metabolics ETF Rating $29.45 -0.26 (-0.88%) As of 03:24 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends Tema Cardiovascular and Metabolics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.80Holdings in HRTS have an aggregate rating of Moderate Buy based on 627 analyst ratings issued in the past year covering 37 companies (82.8% of the portfolio).HRTS Aggregate Price Target$29.45High Prediction$29.45Average Prediction$29.45Low Prediction$29.45Holdings in HRTS have an aggregate price target of $29.45 and a range of $29.45 to $29.45 covering 37 companies (82.8% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Cardiovascular and Metabolics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.66%LLYEli Lilly and Company$798.39-2.9%4.8324 of 5 stars2.85$1,009.72 26.5%20Insider TradePositive News5.23%UNHUnitedHealth Group$480.79-0.1%4.9825 of 5 stars3.10$629.32 30.9%21Ex-DividendAnalyst RevisionPositive News3.95%BBIOBridgeBio Pharma$32.31-0.9%4.4593 of 5 stars2.92$51.55 59.5%123.79%ABTAbbott Laboratories$129.71-0.4%4.8492 of 5 stars2.84$137.94 6.3%19Analyst ForecastPositive News3.72%RHHBYRoche$42.86-1.6%N/A2.506Short Interest ↑News Coverage3.61%VRTXVertex Pharmaceuticals$502.92+1.5%3.8047 of 5 stars2.65$506.70 0.8%26Analyst UpgradeInsider TradePositive News3.34%MRKMerck & Co., Inc.$94.64+1.4%4.9951 of 5 stars2.65$117.12 23.7%23Short Interest ↑3.09%TMOThermo Fisher Scientific$508.62-0.8%4.8589 of 5 stars2.82$653.23 28.4%22Insider TradePositive News2.96%MDTMedtronic$92.30+0.9%4.355 of 5 stars2.44$96.07 4.1%16Dividend AnnouncementPositive News2.93%BSXBoston Scientific$95.33-1.1%4.5274 of 5 stars3.00$108.91 14.2%23Positive News2.73%GILDGilead Sciences$113.35-0.6%4.3775 of 5 stars2.72$104.52 -7.8%29Analyst ForecastInsider TradeOptions VolumePositive News2.70%AMGNAmgen$312.64+0.0%4.0366 of 5 stars2.46$314.04 0.4%24Analyst RevisionPositive News2.52%ABBVAbbVie$211.19-0.4%4.6493 of 5 stars2.88$211.45 0.1%24Positive News2.18%CRNXCrinetics Pharmaceuticals$35.04-1.0%4.1868 of 5 stars2.92$72.64 107.3%13Positive News1.96%DHRDanaher$203.96-0.5%4.8913 of 5 stars2.71$278.00 36.3%21Short Interest ↑Positive News1.93%CYTKCytokinetics$44.40+0.9%4.2933 of 5 stars2.94$82.00 84.7%181.93%BMYBristol-Myers Squibb$60.22+0.7%4.3134 of 5 stars2.32$57.86 -3.9%19Short Interest ↑Analyst RevisionPositive News1.90%REGNRegeneron Pharmaceuticals$680.61-1.3%4.6543 of 5 stars2.76$973.13 43.0%25Short Interest ↑1.89%EWEdwards Lifesciences$67.92-0.9%4.8189 of 5 stars2.42$79.95 17.7%26Insider TradeShort Interest ↓1.83%DXCMDexCom$68.48-3.2%4.8499 of 5 stars2.94$99.82 45.8%18Insider TradeAnalyst Revision1.76%PODDInsulet$244.67-1.5%4.235 of 5 stars2.82$292.06 19.4%17Short Interest ↑1.70%ALNYAlnylam Pharmaceuticals$241.75-0.3%4.8238 of 5 stars2.72$304.26 25.9%25Analyst ForecastShort Interest ↓Analyst Revision1.56%MCKMcKesson$642.65+0.3%4.5328 of 5 stars2.93$645.79 0.5%15Positive News1.49%ASNDAscendis Pharma A/S$152.31+1.3%3.0135 of 5 stars2.93$202.36 32.9%14Positive News1.35%MASIMasimo$165.69-1.2%3.3654 of 5 stars2.83$194.80 17.6%6Insider Trade1.22%MDGLMadrigal Pharmaceuticals$323.02-1.3%3.9422 of 5 stars2.85$375.75 16.3%131.00%MREOMereo BioPharma Group$2.50-1.6%2.7875 of 5 stars3.43$7.83 213.3%7Positive News0.90%ARWRArrowhead Pharmaceuticals$15.07-4.4%3.5652 of 5 stars2.60$41.44 175.0%100.90%AKROAkero Therapeutics$44.86-2.2%4.0815 of 5 stars3.00$76.29 70.1%9Insider Trade0.90%INSMInsmed$75.07+1.4%3.7121 of 5 stars3.00$93.33 24.3%160.88%RCKTRocket Pharmaceuticals$8.50-3.4%4.7103 of 5 stars2.92$43.00 405.9%12Analyst Forecast0.86%MIRMMirum Pharmaceuticals$44.56-1.0%4.1011 of 5 stars3.09$58.20 30.6%11Positive News0.84%IONSIonis Pharmaceuticals$32.90-1.5%4.2782 of 5 stars2.70$59.56 81.0%20Analyst Forecast0.82%GPCRStructure Therapeutics$20.40-4.8%2.092 of 5 stars3.00$81.29 298.5%8News Coverage0.81%WSTWest Pharmaceutical Services$224.01-0.1%4.8379 of 5 stars2.83$344.00 53.6%6Analyst Revision0.63%VKTXViking Therapeutics$29.73+0.6%4.3933 of 5 stars3.00$96.31 223.9%14Analyst ForecastNews Coverage0.33%NTLAIntellia Therapeutics$9.22-4.2%4.4363 of 5 stars2.63$37.56 307.3%19 This page (NASDAQ:HRTS) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
